Safety Study of Immune System Modulator for Autoimmune Diseases

Clinical trial NCT02243683 · COMPLETED

Trial details

NCT number: NCT02243683
Sponsor: Artax Biopharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2014-09-01
Primary completion: 2014-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.